PubMed

Interaction of beta-blockers with the renal uptake transporter OCT2.

Bachmakov I, Glaeser H, Endress B, Mörl F, König J, Fromm MF.

Diabetes Obes Metab. 2009 Nov;11(11):1080-3. Epub 2009 Sep 9.PMID: 19740083 [PubMed - in process]Related articles

Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1.

Bachmakov I, Glaeser H, Fromm MF, König J.

Diabetes. 2008 Jun;57(6):1463-9. Epub 2008 Feb 26.PMID: 18314419 [PubMed - indexed for MEDLINE]Related articlesFree article

The association of ABCB1 polymorphisms and elevated serum digitoxin concentrations in geriatric patients.

Dragonas C, Wagner JT, Heppner HJ, Bertsch T, Muhlberg W, Wicklein S, Pahl A, Diewald C, Bachmakov I, Sieber CC, Fromm MF.

Eur J Clin Pharmacol. 2008 Apr;64(4):367-72. Epub 2007 Dec 16.PMID: 18080812 [PubMed - indexed for MEDLINE]Related articles

Role of p-glycoprotein inhibition for drug interactions: evidence from in vitro and pharmacoepidemiological studies.

Eberl S, Renner B, Neubert A, Reisig M, Bachmakov I, König J, Dörje F, Mürdter TE, Ackermann A, Dormann H, Gassmann KG, Hahn EG, Zierhut S, Brune K, Fromm MF.

Clin Pharmacokinet. 2007;46(12):1039-49.PMID: 18027988 [PubMed - indexed for MEDLINE]Related articles

Impact of the CYP3A5 genotype on midazolam pharmacokinetics and pharmacodynamics during intensive care sedation.

Fromm MF, Schwilden H, Bachmakov I, König J, Bremer F, Schüttler J.

Eur J Clin Pharmacol. 2007 Dec;63(12):1129-33. Epub 2007 Sep 5.PMID: 17786417 [PubMed - indexed for MEDLINE]Related articles

Variability in human hepatic MRP4 expression: influence of cholestasis and genotype.

Gradhand U, Lang T, Schaeffeler E, Glaeser H, Tegude H, Klein K, Fritz P, Jedlitschky G, Kroemer HK, Bachmakov I, Anwald B, Kerb R, Zanger UM, Eichelbaum M, Schwab M, Fromm MF.

Pharmacogenomics J. 2008 Feb;8(1):42-52. Epub 2007 Apr 3.PMID: 17404579 [PubMed - indexed for MEDLINE]Related articles

Characterization of beta-adrenoceptor antagonists as substrates and inhibitors of the drug transporter P-glycoprotein.

Bachmakov I, Werner U, Endress B, Auge D, Fromm MF.

Fundam Clin Pharmacol. 2006 Jun;20(3):273-82.PMID: 16671962 [PubMed - indexed for MEDLINE]Related articles

Simultaneous determination of oxycodone and its major metabolite, noroxycodone, in human plasma by high-performance liquid chromatography.

Cheremina O, Bachmakov I, Neubert A, Brune K, Fromm MF, Hinz B.

Biomed Chromatogr. 2005 Dec;19(10):777-82.PMID: 15920700 [PubMed - indexed for MEDLINE]Related articles

Characterisation of (R/S)-propafenone and its metabolites as substrates and inhibitors of P-glycoprotein.

Bachmakov I, Rekersbrink S, Hofmann U, Eichelbaum M, Fromm MF.

Naunyn Schmiedebergs Arch Pharmacol. 2005 Mar;371(3):195-201. Epub 2005 Apr 15.PMID: 15900513 [PubMed - indexed for MEDLINE]Related articles